Injective’s latest upgrade introduces a native EVM, enabling seamless cross-chain interoperability and boosting DeFi with faster transactions and low fees.
Injective (INJ) is down 3.28% to $12.79 with a 22.2% drop in trading volume, suggesting reduced market activity and testing key support for a potential rebound.
Injective partners with Republic to expand tokenized private markets, offering global investors secure access to on-chain finance.
Injective’s latest upgrade introduces a native EVM, enabling seamless cross-chain interoperability and boosting DeFi with faster transactions and low fees.
Injective (INJ) is down 3.28% to $12.79 with a 22.2% drop in trading volume, suggesting reduced market activity and testing key support for a potential rebound.
Injective partners with Republic to expand tokenized private markets, offering global investors secure access to on-chain finance.
Skip to content
